sitem-insel – the Swiss Institute for Translational and Entrepreneurial Medicine in Berne – has been created to establish, operate and develop a National Center of Excellence for Translational Medicine. Translational medicine is a new, process-oriented discipline that aims to translate new findings and products emerging from private-sector development and basic research into clinical applications.
A major criticism of the current translation process is the lack of professionalization. Therefore, the sitem-insel School aims to promote researchers and train executives in the fields of translational medicine and biomedical entrepreneurship. Lecturers and supervisors of the
school are representatives from research and development-oriented private companies, scientists from universities, clinicians, collaborators from regulatory agencies and financial experts.
Participants are expected to acquire the necessary skills to initiate and implement the translation process from the stage of development in industrial or basic science institutions into clinical applications with the ultimate purpose of the latters’ commercialization. The acquired theoretical knowledge can be applied to the participants’ own projects in order to provide possible strategies to each individual project.
The program is approved by the University of Bern and participants may obtain the degrees of «Master of Advanced Studies» (MAS), «Diploma of Advanced Studies» (DAS) or «Certificate of Advanced Studies» (CAS).